Vertex Pharmaceuticals Inc. buy Wells Fargo & Company
Start price
24.06.24
/
50%
€439.95
Target price
24.06.25
€516.65
Performance (%)
-11.44%
End price
25.06.25
€389.60
Summary
This prediction ended on 25.06.25 with a price of €389.60. The prediction for Vertex Pharmaceuticals Inc. disappointed with a performance of -11.44%. Wells_Fargo___Compan has a follow-up prediction for Vertex Pharmaceuticals Inc. where he still thinks Vertex Pharmaceuticals Inc. is a Buy. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vertex Pharmaceuticals Inc. | 2.106% | 2.106% | -12.192% |
| iShares Core DAX® | 0.795% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -3.088% | -0.762% | 3.169% |
| iShares Nikkei 225® | -0.952% | -2.268% | 12.208% |
| iShares S&P 500 | -1.393% | 0.199% | 1.698% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Trading Vertex Pharmaceuticals Inc.
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at Wells Fargo & Company from $540.00 to $555.00. They now have an "overweight" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Current prediction by Wells_Fargo___Compan for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€398.50
10.01.25
10.01.25
€447.72
10.01.26
10.01.26
-3.01%
15:45
15:45
Stopped prediction by Wells_Fargo___Compan for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€380.75
10.12.25
10.12.25
€442.18
10.12.26
10.12.26
1.51%
15:45
15:45
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€325.60
06.08.25
06.08.25
€397.62
06.08.26
06.08.26
18.70%
15:45
15:45
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€383.95
06.02.24
06.02.24
€502.09
06.02.25
06.02.25
21.15%
07.02.25
07.02.25